Results from 2 studies suggest that adding ICIs to treatment can improve outcomes for patients with resectable HNSCC.

Surgery is a mainstay treatment for head and neck squamous cell carcinoma (HNSCC). However, the clinical challenge is to ...

Immunotherapy shows promise in reducing recurrence rates for high-risk skin cancer, despite mixed results in recent clinical ...